Cargando…
731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
Autores principales: | Dailey, Joelynn, Hyams, Jeffrey S., Hopkins, Dena, Grandonico, Kristen, Brimacombe, Michael, Lapin, Blaine, Schreiber, John, Kozhaya, Lina, Dogan, Mikail, Placek, Lindsey, Renzullo, Stephanie, Gunter, Courtney L., Salazar, Juan C., Unutmaz, Derya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108149/ http://dx.doi.org/10.1016/S0016-5085(21)01104-5 |
Ejemplares similares
-
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
por: Dailey, Joelynn, et al.
Publicado: (2021) -
Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE2
por: Dogan, Mikail, et al.
Publicado: (2022) -
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
por: Dogan, Mikail, et al.
Publicado: (2021) -
Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells
por: Mercer, Frances, et al.
Publicado: (2010) -
Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
por: Russell, Lindsey, et al.
Publicado: (2022)